Fetal surgery for myelomeningocele.
Although in utero treatment of myelomeningocele shows promise in decreasing the morbidity of this disease, the risks to the fetus are significant, and the benefits are unproven. The upcoming trial represents one of the few times that the pediatric neurosurgical community has come together to test a new procedure.